Rocío Montes de Oca

Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design.

S. Trudel, P. Richardson, N. Callander, 2021, Future oncology.

Binding of Barrier to Autointegration Factor (BAF) to Histone H3 and Selected Linker Histones Including H1.1*

K. Wilson, Kenneth K. Lee, Rocío Montes de Oca, 2005, Journal of Biological Chemistry.